Form 4 for MRNA Moderna
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-27 · accession 0001127602-22-016216 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-01 | 2022-05-27 | MRNA | Andres Juan | See remarks | M - OptEx | $135.80 | +1,807 | 11.1K | +19% | +$245.4K |
| D | 2022-06-01 | 2022-05-31 | MRNA | Andres Juan | See remarks | S - Sale+OE | $145.40 | -749 | 10.4K | -7% | -$108.9K |
| D | 2022-06-01 | 2022-05-27 | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -1,807 | 12.7K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | M | A | 1,807 | $135.80 | 11,116 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-31 | S | D | 749 | $145.40 | 10,367 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-05-27 | M | D | 1,807 | $0.00 | 12,655 | D | $0.00 · — to — | 1,807 Common Stock | (F3) 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter. |